Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

February 28, 2010

Conditions
Kidney Transplant Dysfunction
Trial Locations (1)

11040

Schneider Children's Hospital, New Hyde Park

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Northwell Health

OTHER